Published in Drug Metab Dispos on September 07, 2007
Drug interactions with new and investigational antiretrovirals. Clin Pharmacokinet (2009) 1.77
Pharmacokinetic/pharmacodynamic modeling of the antiretroviral activity of the CCR5 antagonist Vicriviroc in treatment experienced HIV-infected subjects (ACTG protocol 5211). J Acquir Immune Defic Syndr (2010) 0.77
CYP2J2 and CYP2C19 are the major enzymes responsible for metabolism of albendazole and fenbendazole in human liver microsomes and recombinant P450 assay systems. Antimicrob Agents Chemother (2013) 0.75
Targeting CCR5 for anti-HIV research. Eur J Clin Microbiol Infect Dis (2014) 0.75
Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet (2006) 4.35
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol (2011) 4.09
Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc Natl Acad Sci U S A (2006) 3.09
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature (2013) 3.00
MicroRNA, mRNA, and protein expression link development and aging in human and macaque brain. Genome Res (2010) 2.44
Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet (2005) 2.25
Oxidized LDL downregulates ATP-binding cassette transporter-1 in human vascular endothelial cells via inhibiting liver X receptor (LXR). Cardiovasc Res (2005) 1.99
Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin Infect Dis (2011) 1.87
Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas. Nat Genet (2013) 1.80
Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron (2012) 1.78
Perilipin 5 improves hepatic lipotoxicity by inhibiting lipolysis. Hepatology (2015) 1.55
Pathological cardiac hypertrophy alters intracellular targeting of phosphodiesterase type 5 from nitric oxide synthase-3 to natriuretic peptide signaling. Circulation (2012) 1.51
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in cancer: a meta-analysis. Gene (2012) 1.44
The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J Immunol (2010) 1.44
Helicobacter pylori detection by polymerase chain reaction in pediatric gastritis. J Pediatr Gastroenterol Nutr (2012) 1.43
Quantitative analysis of hemoglobin content in polymeric nanoparticles as blood substitutes using Fourier transform infrared spectroscopy. J Mater Sci Mater Med (2010) 1.41
Molecular pharmacognosy: a new borderline discipline. Nat Prod Commun (2009) 1.39
Hydrodynamics of biological aggregates of different sludge ages: an insight into the mass transport mechanisms of bioaggregates. Environ Sci Technol (2003) 1.38
Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan. Biomaterials (2009) 1.35
Intergenic and repeat transcription in human, chimpanzee and macaque brains measured by RNA-Seq. PLoS Comput Biol (2010) 1.33
Design and testing of a microfluidic biochip for cytokine enzyme-linked immunosorbent assay. Biomicrofluidics (2009) 1.33
Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies. Hum Mol Genet (2012) 1.28
Extension of cortical synaptic development distinguishes humans from chimpanzees and macaques. Genome Res (2012) 1.27
Widespread splicing changes in human brain development and aging. Mol Syst Biol (2013) 1.23
Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects. Drug Metab Dispos (2002) 1.19
Gastric cancer incidence and mortality in Zhuanghe, China, between 2005 and 2010. World J Gastroenterol (2012) 1.19
Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of posaconazole (Noxafil). Drug Metab Dispos (2004) 1.18
Risk of gastric cancer is associated with the MUC1 568 A/G polymorphism. Int J Oncol (2009) 1.18
BM-map: Bayesian mapping of multireads for next-generation sequencing data. Biometrics (2011) 1.11
Fhb, a novel factor H-binding surface protein, contributes to the antiphagocytic ability and virulence of Streptococcus suis. Infect Immun (2012) 1.11
Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy. Cardiovasc Diabetol (2011) 1.11
Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Med Oncol (2013) 1.11
A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse. Brain Struct Funct (2011) 1.09
Recovery from DNA damage-induced G2 arrest requires actin-binding protein filamin-A/actin-binding protein 280. J Biol Chem (2003) 1.09
Mutations in TRPV4 cause an inherited arthropathy of hands and feet. Nat Genet (2011) 1.07
Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia). Drug Metab Dispos (2004) 1.07
Characterization of human liver enzymes involved in the biotransformation of boceprevir, a hepatitis C virus protease inhibitor. Drug Metab Dispos (2010) 1.05
Prospective cohort study of comprehensive prevention to gastric cancer. World J Gastroenterol (2003) 1.04
Breast mass segmentation in mammography using plane fitting and dynamic programming. Acad Radiol (2009) 1.03
Intestinal lymphatic transport for drug delivery. Adv Drug Deliv Rev (2011) 1.02
Serum pepsinogen II: a neglected but useful biomarker to differentiate between diseased and normal stomachs. J Gastroenterol Hepatol (2011) 1.01
Sequence-specific capture of protein-DNA complexes for mass spectrometric protein identification. PLoS One (2011) 1.01
In vitro cytotoxicity and induction of apoptosis by silica nanoparticles in human HepG2 hepatoma cells. Int J Nanomedicine (2011) 1.00
A PKC-beta inhibitor treatment reverses cardiac microvascular barrier dysfunction in diabetic rats. Microvasc Res (2010) 0.99
Helicobacter pylori-related host gene polymorphisms associated with susceptibility of gastric carcinogenesis: a two-stage case-control study in Chinese. Carcinogenesis (2013) 0.97
Role of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancer. Anticancer Drugs (2013) 0.97
Salient Band Selection for Hyperspectral Image Classification via Manifold Ranking. IEEE Trans Neural Netw Learn Syst (2016) 0.96
A PKC-beta inhibitor protects against cardiac microvascular ischemia reperfusion injury in diabetic rats. Apoptosis (2010) 0.96
Hyperspectral Anomaly Detection by Graph Pixel Selection. IEEE Trans Cybern (2015) 0.96
Serum pepsinogen levels and their influencing factors: a population-based study in 6990 Chinese from North China. World J Gastroenterol (2007) 0.96
Promoter polymorphisms in DNA repair gene ERCC5 and susceptibility to gastric cancer in Chinese. Gene (2012) 0.95
In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content. J Mater Sci Mater Med (2009) 0.95
Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases. World J Gastroenterol (2005) 0.95
Effective feature extraction in high-dimensional space. IEEE Trans Syst Man Cybern B Cybern (2008) 0.95
Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder. Int J Clin Exp Pathol (2013) 0.94
Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models. Phytother Res (2008) 0.94
Early diagnostic value of survivin and its alternative splice variants in breast cancer. BMC Cancer (2014) 0.94
Nanoparticle-based biocompatible and long-life marker for lysosome labeling and tracking. Anal Chem (2010) 0.93
[Correlation of interleukin-10-1082G/a single nucleotide polymorphism to the risk of gastric cancer in north China: a case-control study]. Ai Zheng (2008) 0.93
Preparation of liposomal brucine and its pharmaceutical/pharmacodynamic characterization. Acta Pharmacol Sin (2007) 0.93
Identification and characterization of novel immunogenic proteins of Streptococcus suis serotype 2. J Proteome Res (2008) 0.93
Streptococcus suis adenosine synthase functions as an effector in evasion of PMN-mediated innate immunit. J Infect Dis (2014) 0.93
Phosphatase PTEN is critically involved in post-myocardial infarction remodeling through the Akt/interleukin-10 signaling pathway. Basic Res Cardiol (2012) 0.92
Progressive impairment of muscle regeneration in muscleblind-like 3 isoform knockout mice. Hum Mol Genet (2013) 0.92
Proteome analysis of Streptococcus suis serotype 2. Proteomics (2008) 0.92
Pre-miR-27a rs895819A/G polymorphisms in cancer: a meta-analysis. PLoS One (2013) 0.92
Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers. Biomaterials (2006) 0.92
Phytoplankton depth profiles and their transitions near the critical sinking velocity. J Math Biol (2008) 0.92
Development of mussel adhesive polypeptide mimics coating for in-situ inducing re-endothelialization of intravascular stent devices. Biomaterials (2009) 0.91
Expression of gastric cancer-associated MG7 antigen in gastric cancer, precancerous lesions and H. pylori -associated gastric diseases. World J Gastroenterol (2002) 0.91
Segmenting images by combining selected atlases on manifold. Med Image Comput Comput Assist Interv (2011) 0.91
Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes. Biopharm Drug Dispos (2003) 0.91
Tmod: toolbox of motif discovery. Bioinformatics (2009) 0.91
Precision and accuracy in the quantitative analysis of biological samples by accelerator mass spectrometry: application in microdose absolute bioavailability studies. Anal Chem (2011) 0.91
CFL1 and Arp3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinomas of gallbladder. Cancer Invest (2013) 0.91
Association between pepsinogen C gene polymorphism and genetic predisposition to gastric cancer. World J Gastroenterol (2003) 0.90
Combined tamoxifen and gefitinib in non-small cell lung cancer shows antiproliferative effects. Biomed Pharmacother (2009) 0.90
Selective promoter recognition by chlamydial sigma28 holoenzyme. J Bacteriol (2006) 0.90
Identification of human liver cytochrome P450 enzymes involved in the metabolism of SCH 530348 (Vorapaxar), a potent oral thrombin protease-activated receptor 1 antagonist. Drug Metab Dispos (2010) 0.90
Sparse coding from a Bayesian perspective. IEEE Trans Neural Netw Learn Syst (2013) 0.90
Chromatin-targeting small molecules cause class-specific transcriptional changes in pancreatic endocrine cells. Proc Natl Acad Sci U S A (2012) 0.89
Laparoscopic versus open surgery for colon cancer: a meta-analysis of 5-year follow-up outcomes. Surg Oncol (2013) 0.89
Positive ALDH1A3 and negative GPX3 expressions are biomarkers for poor prognosis of gallbladder cancer. Dis Markers (2013) 0.89
A meta-analysis of 2-year effect after surgery: laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity and diabetes mellitus. Obes Surg (2014) 0.88
Low density lipoprotein induces eNOS translocation to membrane caveolae: the role of RhoA activation and stress fiber formation. Biochim Biophys Acta (2003) 0.88
Association of cyclooxygenase-2 expression with Hp-cagA infection in gastric cancer. World J Gastroenterol (2003) 0.88
Mutation of the light-induced yellow leaf 1 gene, which encodes a geranylgeranyl reductase, affects chlorophyll biosynthesis and light sensitivity in rice. PLoS One (2013) 0.88
Impact of pepsinogen C polymorphism on individual susceptibility to gastric cancer and its precancerous conditions in a Northeast Chinese population. J Cancer Res Clin Oncol (2009) 0.88